INTRODUCTION
Once overlooked as merely a passive lining of blood vessels, endothelial cells (ECs) are increasingly recognized as active participants in vascular homeostasis. A particularly important responsibility of the endothelium is to form new blood vessels in a complex and energy-intensive process known as angiogenesis. To fuel angiogenesis, ECs are adept at utilizing glucose as an energy source 1 , which allows ECs to proliferate and vascularize hypoxic tissue while preserving oxygen for perivascular cells. Despite a reliance on glycolysis, ECs contain functional mitochondria that are active during angiogenesis 2 . Endothelial mitochondria are therefore considered signaling organelles that modulate the angiogenic process 3 or supply biosynthetic molecules required for growth 4 . Precisely how mitochondrial metabolism impacts endothelial function and angiogenesis is virtually unknown.
An intriguing means to manipulate angiogenesis may involve the mitochondrial permeability transition pore (mPTP). Arsenic-based compounds that target a purported component of the mPTP have an uncanny ability to inhibit endothelial mitochondrial function and angiogenesis in solid tumors 6 and are being developed as anticancer therapies in patients 7 . Pathologically, mPTP activation terminates mitochondrial function and triggers cell death 8 . However, accumulating evidence support a non-lethal role for the mPTP in mitochondrial Ca 2+ homeostasis, bioenergetics and redox signaling 9 . The mitochondrial matrix protein Cyclophilin D (CypD), which is encoded by the nuclear gene Ppif and inhibited by cyclosporine A (CsA), is a key regulator of Ca 2+ -induced mPTP opening 10 . Indeed, mitochondria isolated from CypD KO mice have an increased Ca 2+ retention capacity compared to WT counterparts 11 . As a result, CypD KO mice possess alterations in glucose oxidation that render cardiomyocytes metabolically inflexible and prone to heart failure 12 . CypD KO mice also exhibit changes in branch chain amino acid, pyruvate, and Krebs cycle metabolism 13 .
Given that ECs are predominately glycolytic and inherently metabolically inflexible, it is unclear whether the mPTP plays a physiologic role in the vascular intima. Our studies demonstrate a fundamental role for the endothelial mPTP in matrix Ca 2+ homeostasis and mitochondrial bioenergetics. Genetic CypD targeting in both ECs and mice enhances mitochondrial Ca 2+ loading and triggers a persistent alteration in cellular NAD + /NADH homeostasis. Phenotypically, the reduction in the cytosolic NAD + /NADH ratio reduces SIRT1 expression, which downregulates PTEN and results in constitutive Akt phosphorylation. As a result, both CypD-deficient ECs and CypD KO mice exhibit enhanced angiogenesis in vitro, ex vivo and in vivo upon tissue injury. In total, these findings elucidate a novel pathway by which mitochondrial bioenergetics influence vascular function, as well as define a Mitochondria-SIRT1 signaling axis that may have broad implications in cell biology.
[Ca 2+ ] measurement. Mitochondrial [Ca 2+ ] was measured by confocal microscopy using the FRET-based mitochondrial Ca 2+ indicator Cameleon D3cpv 15 (Addgene 36324). Cytosolic [Ca 2+ ] was measured by fluorescence microscopy using Fura-2 AM (Molecular Probes).
NADH and NAD
+ /NADH ratio measurements. Mitochondrial NAD(P)H autofluorescence was measured by fluorescence microscopy with an UV filter. Cytosolic NAD + /NADH ratio was measured using Peredox 17 (Addgene 32383). Total intracellular NAD + /NADH ratio was measured using the NAD + /NADH Quantitation Kit (BioVision) and the EnzyChrom NAD + /NADH Assay Kit (BioAssay Systems). Lactate and pyruvate concentrations were measured using Lactate and Pyruvate Assay Kits (Cayman Chemical).
Mitochondrial mass, membrane potential and superoxide production. Mitochondrial mass, membrane potential and superoxide were quantified by flow cytometry using MitoTracker Green, tetramethylrhodamine methyl ester (TMRM), 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) and MitoSox Red (Invitrogen).
Cellular respiration.
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured using the XF24 Analyzer (Seahorse Bioscience).
Invasion assay.
HPAECs were seeded on collagen and provided VEGF every 3 rd day. After 7 days, the collagen layer was fixed and stained with primary antibodies against CD31 and Ki67. Image stacks (5 m) were acquired with a LSM510 META Zeiss confocal microscope and endothelial invasion was quantified by CD31 positivity >5 m from the plane of focus.
Aortic rings angiogenesis assay.
Aortic rings embedded in collagen type I matrix were stimulated with 30 or 90 ng/ml VEGF every 3 rd day for 9 days, fixed, stained with DAPI and imaged with a Zeiss Axiovert200 fluorescence microscope. The number of primary and secondary sprouts was quantified in a blinded manner.
Ear wound healing assay. Mouse ear pinna was excised using a 0.5 mm biopsy punch and pictures of the wound were taken biweekly to measure wound size. Microvascular changes during wound healing were visualized and quantified by optical microangiography (OMAG) by the mitochondrial form factor ( Figure 1C, Online Figures IA, IB) , a morphological change reflected by a more complex and reticulated mitochondrial network in Ppif siRNA HPAECs ( Figure 1D Figure IE) . In total, these findings indicate that the mPTP is an important regulator of endothelial mitochondrial Ca 2+ homeostasis.
CypD influences endothelial mitochondrial functions.
The elevated basal [Ca 2+ ] m in CypD-deficient ECs would likely elicit mitochondrial functional alterations. Indeed, CypD deletion evoked a significant rise in mitochondrial membrane potential as detected by the cationic fluorescent indicators TMRM ( Figure 2A ) and JC-1 ( Figure 2B ). The rise in membrane potential corresponded with elevated basal respiration: 59.95  2.24 pmol/min O 2 for Ppif siRNA ECs compared to 30.98  1.34 pmol/min for control cells ( Figure 2C, 2D) . Inhibition of ATP synthase by oligomycin lowered OCR to similar levels in both CypD-deficient and control ECs, indicating that the elevation in respiration was coupled to ATP production. However there was no effect of CypD targeting on overall cellular ATP levels in either proliferating or confluent ECs ( Figure 2E ). Moreover, lactate production (as detected by ECAR) was similar between CypD-deficient and control ECs ( Figure 2F ), indicating that CypD knockdown did not simply shift energy production from the cytosol to the mitochondria. Rather, this data suggests increased mitochondrial ATP generation paired with ATP consumption, resulting in a net neutral ATP level. Increased endothelial respiration also evoked mitochondrial ROS generation ( Figure 2G ) that would imply CypD-deficient ECs might be less metabolically robust and more prone to dysfunction and death. Paradoxically, CypD-deficient ECs appear to be better able to respond to increases in energy demand as denoted by a significant increase in spare respiratory capacity ( Figure 2H ) suggesting that CypD targeting conveys a protective cellular phenotype.
Endothelial mPTP inactivation triggers NADH accumulation and alters cytosolic NAD
+ /NADH homeostasis.
Mitochondrial Ca

2+
activates Ca 2+ -sensitive dehydrogenases that increase NADH production 21 in order to drive respiration. Consistent with the measured increase in [Ca 2+ ] m and OCR, CypD-deficient ECs exhibited a 27.5  0.032% rise in basal mitochondrial NAD(P)H autofluorescence versus controls ( Figure  3A ). Recent data from our laboratory has shown that histamine stimulation of ECs results in mitochondrial Ca 2+ loading and persistent accumulation of NAD(P)H in the matrix 22 . However, histamine stimulation of CypD-deficient ECs did not further increase mitochondrial NAD(P)H ( Figure 3B) 23 . As such, direct measurement of total cellular NADH revealed that mPTP inhibition with CsA stimulated NADH production (Online Figure IF) and a reciprocal reduction in the NAD + /NADH ratio to a similar degree as acute mitochondrial Ca 2+ loading using histamine (Online Figure IH) . No significant changes in NAD + levels were detected (Online Figure IG) . To recapitulate these results in vivo, the NAD + /NADH ratio was measured in tissues obtained from CypD KO mice, the mitochondria from which exhibit an enhanced ability to sequester Ca 2+ ( Figure 3C ). Similar to ECs, CypD KO mice had a decreased NAD + /NADH ratio in both the aorta and endothelial-rich lung tissue when assessing total cellular NAD + and NADH ( Figure 3D Figures 4C, 4D ). Immortalized human pulmonary microvascular ECs (HPMVECs) in which CypD was targeted using shRNA also exhibited reduced SIRT1 protein levels ( Figures 4C, 4D) , demonstrating that the CypD-mediated regulation of SIRT1 is not exclusive to the aorta and pulmonary artery. Indeed, follow-up analysis revealed a strong positive correlation between CypD and SIRT1 expression in both HPAECs and HPMVECs ( Figure 4E ). Pharmacologic inhibition of mitochondrial Ca A reduction in SIRT1 expression concomitant with a decrease in NAD + /NADH ratio would predictably trigger an increase in protein acetylation. Indeed, overall protein acetylation was elevated in both CypD KO aortic and lung tissues ( Figures 4F, 4G) . No difference in the protein levels of the acetyl transferase CBP was noted between control and CypD-deficient cells (Online Figures IIB, IIC) , implying that acetylation was due to diminished deacetylation. SIRT1 expression was restored by NMN supplementation, confirming that SIRT1 levels were responsive to [NAD + /NADH] cyt ( Figure 4H ). We hypothesized that SIRT1 regulation in CypD-deficient ECs may be tied to the NAD + /NADH ratio by the actions of the NADH-sensitive transcription factor CtBP (C-terminal binding protein) 28 . However, we found no significant difference in CtBP expression between control and CypD-deficient ECs (Online Figures IIB, IID), suggesting an alternative mechanism for SIRT1 regulation.
CypD-mediated SIRT1 alterations influence PTEN expression and Akt phosphorylation.
Phosphatase and tensin homolog (PTEN) is indispensible for angiogenesis 29 and has been implicated in vascular function in diabetes 30 . SIRT1 regulates PTEN acetylation and enzymatic activity 31 , but has no known role in PTEN expression. A reduction in both CypD and SIRT1 corresponded to diminished PTEN expression in ECs ( Figure 5A ). Inhibition of Ca While PTEN immunoprecipitation could not be performed in aortic homogenate, CypD KO aortic tissue did exhibit increased acetylation that corresponded to PTEN via western blotting (Online Figure IIIE) . Liver tissue obtained from CypD KO mice exhibits an overall increase in acetylation (Online Figure IIIF ) similar to the aorta and lung. PTEN immunoprecipitated from CypD KO liver homogenate revealed significant acetylation compared to the WT control (Online Figures IIIG, IIIH) . Therefore, genetic inactivation of CypD in ECs and tissues results in PTEN downregulation and/or increased acetylation that would diminish enzyme activity.
Akt is an important downstream target of PTEN that is phosphorylated by numerous agonists such as histamine 32 and VEGF 33 . Consistent with a reduction in PTEN activity and/or expression, CypD genetic knockdown effectively increased Akt phosphorylation in unstimulated HPAECs and HPMVECs ( Figure  5A ) as well as in aortic and lung tissue from CypD KO mice ( Figure 5C ). Genetic targeting of SIRT1 by siRNA resulted in significant decrease in PTEN and a coincident increase in Akt phosphorylation that was unresponsive to NMN ( Figure 5E ). Conversely, PTEN overexpression in CypD-deficient HPAECs reduced basal Akt phosphorylation without altering SIRT1 levels ( Figure 5F ) 34 (Addgene plasmid 10750). Taken together, these findings demonstrate that PTEN is downstream of SIRT1 and its expression is governed by the [NAD + /NADH] cyt in CypD-deficient ECs. Pharmacologic inhibition of SIRT1 deacetylase activity with nicotinamide also resulted in increased Akt activation ( Figure 5D ).
CypD deletion increases endothelial proliferation and angiogenesis.
CypD-deficient ECs displayed a significant increase in cell number that calculated as 23.4  1.02% reduction in doubling time and was normalized by NMN ( Figure 6A ). Challenging CypD-deficient HPAECs with VEGF evoked an even further increase in Akt phosphorylation versus controls ( Figure 6B ), suggesting that CypD targeting may increase the inherent angiogenic potential of ECs. CypD-deficient HPAECs were therefore plated on collagen matrix and endothelial invasion evaluated after 7 days in culture ( Figure 6C ) both in the absence and presence of VEGF and NMN. Western blotting was used to confirm that CypD expression remained depressed during the time course of the invasion assay (Online Figure IVA) . Consistent with decreased doubling time CypD-deficient ECs exhibited an increased invasion frequency both at baseline and in response to VEGF ( Figure 6D ). NMN strongly reduced endothelial invasion in CypD-deficient but not control ECs, supporting the primacy of the [NAD + /NADH] cyt in the CypD-deficient phenotype. Further analysis revealed that CypD-deficient ECs experienced deeper basal invasion depth (25.37  0.58 m SEM, n=278 processes) with early lumen formation versus control ECs (12.3  7.38 m SEM, n=26 processes) that in many cases colocalized with the proliferation marker Ki-67 ( Figure 6C ).
Aortas from WT and CypD KO mice were also evaluated for ex vivo vascular remodeling using the aortic ring angiogenesis assay. In response to VEGF (30 ng/ml), CypD KO aortic rings experienced significantly increased vessel formation (primary sprouts and secondary branches) compared to WT counterparts that was normalized by NMN ( Figures 6E-G) . NMN did not diminish sprout formation in WT aortas in which vessel formation was induced by elevated VEGF (90 ng/ml) (Online Figure IVB) . No differences in VEGF receptor expression were noted between WT and CypD KO aorta and lung tissues (Online Figure IVC) , excluding the possibility that CypD KO mice were simply more responsive to agonist stimulation. To recapitulate our findings in vivo, new vessel formation was monitored during tissue injury by optical microangiography (OMAG) 20 during ear wound healing. CypD KO mice showed earlier onset and significantly accelerated wound closure compared to WT counterparts ( Figure 7A ), which correlated with increased vascular distribution around the wound at 14 days after ear excision ( Figure 7B ). Angiographic quantitation of vessel area density revealed a significant increase in wound area vessel density in CypD KO animals: 0.2180.05 KO vs 0.0480.02 WT (mean SEM, n=3) after wounding but not at baseline ( Figure 7C ). In total, our results support the mitochondrial regulation of angiogenesis through the NAD + /NADH dependent regulation of SIRT1 and PTEN ( Figure 7D ).
DISCUSSION
The discovery that CypD KO mice have a propensity for heart failure 12 has accelerated interest in the physiological actions of the mPTP 35 . In the present study, ECs in which the regulatory subunit CypD was genetically targeted exhibited an increase in both membrane potential and matrix Ca -mediated increase in ATP synthase activity as witnessed by the dramatic reduction in respiration using oligomycin. However, unlike cardiomyocytes where NADH production is effectively paired with consumption, the low energetic requirements of ECs apparently allow mitochondrial NADH production to outpace consumption and accumulate. We noted a similar rise in matrix NADH in response to repetitive Ca 2+ oscillations 22 , further supporting that Ca 2+ is the driving force behind endothelial mitochondrial NADH accumulation, and a reduction in the cellular and the cytosolic NAD + /NADH ratios. A similar buildup of matrix NADH and a reduction in the cellular NAD + /NADH ratio was observed in cardiac tissue in which NADH oxidation was perturbed by genetic deletion of the mitochondrial complex I subunit Ndufs4 39 . As we recently discovered, a buildup of NADH in endothelial mitochondria can transmit to the cytosol, possibly via the reverse activation of the malateaspartate shuttle 22 , which can transmit reducing equivalents from the mitochondria to the cytosol in liver mitochondria 40 .
The [NAD + /NADH] cyt is a key determinant of cytosolic protein acetylation via sirtuins. Both CypDdeficient ECs and CypD KO mice exhibited a significant decline in SIRT1 expression, which is regulated largely by nutrient status and metabolic transcription factors. Our study strengthens the relationship between SIRT1 expression and the [NAD + /NADH] cyt , but is unique in that all experiments were performed under normal nutrient availability. This distinction is important, and reveals that SIRT1 regulation is impacted not only by nutrient availability per se, but also by the mitochondrial integration of Ca /NADH] cyt as an imbalance between energy production and energy demand similar to that triggered by nutrient excess and, as a result, repress SIRT1 expression. SIRT1 expression is depressed in diabetic mice 41 and in patients with chronic obstructive pulmonary disease 42 . Based on our findings, it is interesting to speculate whether endothelial mitochondrial bioenergetics may contribute to SIRT1 downregulation and the vascular complications present in these inflammatory-related diseases. In muscle tissue, SIRT1 diminishes the transcription and activity of PGC1-, which reduces the expression of genes involved in mitochondrial electron transport, transcription, and fatty acid metabolism 43 . However, we detected no changes in PGC1- protein and mRNA levels and mitochondrial biogenesis markers (Online Figures VA-C) , excluding the role of PGC-1 in the CypD endothelial phenotype.
Pharmacologic mPTP blockade protects from ischemia/reperfusion injury by activating pro-survival Akt 44 . Our data support this finding, but also define a linear pathway in which an mPTP-mediated reduction in [NAD + /NADH] cyt downregulates SIRT1, resulting in PTEN inhibition and Akt phosphorylation. As SIRT1 can directly target Akt, lowered SIRT1 expression would theoretically enhance Akt acetylation and diminish its phosphorylation 45 . In contrast, our study indicates that SIRT1 affects Akt indirectly through PTEN inactivation in ECs. A similar relationship between SIRT1 expression and Akt activation was noted in cancer cells 46 due to an increase in PTEN acetylation. Enhanced oxidant generation can also directly inactivate PTEN by triggering both intramolecular cysteine bonding oxidant-mediated enzymatic inactivation is secondary to the reduction in PTEN expression, as NMN completely normalizes SIRT1 levels, PTEN expression, and Akt phosphorylation in CypD-deficient ECs without influencing oxidant generation (Online Figure VD) . This data strongly suggests that it is the NAD + /NADH ratio-mediated regulation of SIRT1 and PTEN expression, and not the increase in mitochondrial oxidant generation, which ultimately drives the CypD-deficient phenotype.
While incredibly varied in clinical presentation, a common thread among cardiovascular disease patients is endothelial dysfunction and impaired angiogenesis either as a primary pathology or as collateral damage. Previous work indicates a positive interaction between SIRT1 and angiogenesis, as genetic SIRT1 deletion retards vessel growth in vivo 49 . In contrast, our results demonstrate a negative relationship between SIRT1 expression and angiogenesis when genetic CypD targeting only diminishes SIRT1 levels, which is more biologically relevant than complete SIRT1 deletion. CypD KO mice typically do not present with an overt pathology, but rather as a latent phenotype that manifests only in the presence of an additional stressor 12 . Indeed our in vivo data show increased neovascularization in CypD KO mice following tissue wounding, but no significant vascular phenotype at baseline. Thus, CypD KO animals may more closely mimic the endothelial dysfunction that occurs in humans during the progression of chronic disease. Further investigation is required to determine the therapeutic implications of our findings, and whether CypDmediated angiogenesis is restricted to oxygenated tissues that can support increased mitochondrial respiration.
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SOURCES OF FUNDING
Cell culture
Primary human pulmonary artery endothelial cells (HPAEC) (Invitrogen) were cultured in M200 medium supplemented with Low Serum Growth Supplement (Invitrogen), 50 U/ml penicillin and 50 µg/ml streptomycin and used between passages 5 and 10. Human pulmonary microvascular endothelial cells (HPMVEC) were cultured in M199 medium supplemented with 20% FBS, 30 µg/ml Endothelial Cell Growth Supplement (Millipore), 2 mmol/L L-glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin. For RNA interference and plasmid expression experiments, HPAEC were transfected using the NEON electroporation system (Invitrogen) with 50 nmol/L siRNA or 0.5 -1 µg DNA/shRNA. Human Ppif siRNA and SIRT1 siRNA were purchased from Ambion and human Ppif shRNA was purchased form Origene. Cells were assayed for protein expression 72 h after transfection. Unless otherwise stated, all experiments were performed on confluent cells plated 2 -3 days before assays.
Animals
CypD-null (B6/129-Ppiftm1Jmol/J homozygote) and strain-matched controls (B6/129SF2/J wild type) were obtained from the Jackson Laboratory. Male mice between 8-14 weeks of age were anaesthetized with pentobarbital (80 mg/kg body weight, IP) and euthanized by severing the abdominal aorta prior to tissue harvest. NMN (100 mg/kg, IP) was delivered 1 hr prior to terminal surgery. All experimental protocols were approved by the University of Washington Institutional Animal Care and Use Committee.
Western blot and Immunoprecipitation
Cells were lysed in RIPA buffer (Sigma) supplemented with protease inhibitor cocktail (Thermo Scientific), phosphatase inhibitors cocktail (Roche), 10 mmol/L nicotinamide and 10 µmol/L trichostatin A. For Western blot, 10 µg proteins were electrophoresed on NuPAGE 4-12% BisTris Acrilamide gels (Invitrogen), transferred on PVDF membrane and probed with primary antibodies at 4°C overnight. For immunoprecipitation, 2 mg cell or tissue lysates were incubated with primary antibody overnight at 4°C followed by incubation with A/G Plus agarose beads (Santa Cruz). HRP-conjugated secondary antibodies (Thermo Scientific) were used for detection. 
Changes in cytosolic [Ca 2+ ] were measured by wide field fluorescence microscopy using the Fura-2 AM dye (Molecular Probes). HPAEC plated on MatTek dishes were loaded with 5 µmol/L Fura-2 AM in ECM buffer supplemented with 100 µmol/L sulfinpyrazone and 0.003% pluronic acid, for 30 min at room temperature. After dye loading cells were washed and imaged in ECM buffer with 0.25% BSA and 100 µmol/L sulfinpyrazone using a Nikon Eclipse Ti microscope equipped with a xenon arc lamp and DeltaRamX monochromator (Photon Technology International), an Evolve 512 EMCCD camera (Photometrics), a 40x/1.30 oil Nikon Plan Fluor objective and using a UV filter. The microscope was calibrated for Fura-2 fluorescence (Molecular Probes) and Ca 2+ concentrations were obtained using the EasyRatioPro software (Photon Technology International). Calcium retention capacity assay was performed on isolated liver mitochondria as described previously ) using 800 nmol/L Fura FF (Invitrogen) to measure changes in extramitochondrial Ca 2+ upon pulsing mitochondria with CaCl 2 at fixed time intervals.
NADH and NAD
+ /NADH ratio measurements Mitochondrial NADH fluorescence was measured with a Nikon Eclipse Ti microscope equipped with a xenon arc lamp and DeltaRamX monochromator (Photon Technology International) and an Evolve 512 EMCCD camera (Photometrics) with the assistance of EasyRatioPro software using a UV filter and a 40x/1.30 oil Nikon Plan Fluor objective. Specificity for mitochondrial NADH was determined by colocalization with the mitochondrial dye MitoTracker Green (Invitrogen). Cytosolic NAD + /NADH ratio was measured using the genetically encoded ratiometric fluorescence indicator Peredox (Hung et al., 2011) (Addgene plasmid 32383). Baseline green and red fluorescence images were acquired every 30 seconds for 5 min with a LSM510 META Zeiss confocal microscope using a Zeiss Fluar 40x/1.3 oil objective at an excitation/emission of 405/505-530 nm and 543/650 nm. Images were background corrected and green-to-red ratio images were obtained using ImageJ software. For each cell, ratio data were normalized to the minimal green-to-red ratio signal obtained with 10 mmol/L pyruvate. The Peredox sensor was calibrated in ECM buffer without glucose by varying extracellular concentrations of lactate and pyruvate as previously described (Hung and Yellen, 2014) . Total intracellular NAD + /NADH ratio was measured using the NAD + /NADH Quantitation Kit (BioVision) for tissue extracts and the EnzyChrom NAD + /NADH Assay Kit (BioAssay Systems) for cell extracts. Intracellular lactate and pyruvate concentrations were measured using the Lactate Assay Kit and Pyruvate Assay Kit (Cayman Chemical) and used to calculate the cytosolic NAD + /NADH ratio .
Mitochondrial mass, membrane potential and superoxide production Mitochondrial mass, membrane potential and superoxide production were quantified in live cells by flow cytometry using a FACS CantoII cells sorter (BD Bioscience). To measure mitochondrial mass, cells were stained with 50 nmol/L MitoTracker Green (Invitrogen) and analyzed by FACS using an excitation/emission of 488/530 nm. To measure mitochondrial membrane potential cells were stained with either 30 nmol/L tetramethylrhodamine methyl ester (TMRM, Invitrogen) or 0.5 µg/ml 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, Invitrogen) and analyzed by FACS at an excitation/emission of 488/585 nm and respectively 488/530 nm (JC-1 monomer ) and 488/585 nm (JC-1 aggregate ). For JC-1 measurements, changes in mitochondrial membrane potential were expressed as changes in the JC-1 aggregate /JC-1 monomer fluorescence ratio. To measure mitochondrial superoxide production cells were stained with 5 µmol/L MitoSox Red (Invitrogen) and analyzed by FACS using an excitation/emission of 488/585 nm. . Gray scale images were processed with a convolve filter followed by a median filter and thresholding and subjected to particle analysis to generate mitochondrion area (A), perimeter (P) and aspect ratio (AR, the ratio between the major and minor axis of the ellipse equivalent to the mitochondrion). The form factor (F) was calculated using the following equation:
Mitochondrial morphology
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Cellular respiration
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured using the XF24 Analyzer (Seahorse Bioscience). HPAECs were transfected with either Ppif siRNA or scrambled siRNA and were plated in Seahorse 24 well assay plates, 30,000 cells/well, in M200 growth medium, 24 hours after transfection. OCR and ECAR measurements were performed in XF Assay medium (Seahorse Bioscience) at 10 min intervals 72 hours after transfection.
ATP content ATP levels were measured using the EnzyLight Assay Kit (BioAssay Systems).
Invasion assay
Invasion assay was performed in polydimethylsiloxane wells, corona treated and coated with polyethyleneimine (bottom chamber: 4 mm diameter, 2 mm height, reservoir: 8 mm diameter, 2 mm height). HPAECs were seeded on top of collagen type I matrix, 40,000 cells/well, and were fed with 50 ng/ml VEGF every 3 rd day. Cells were allowed to invade the collagen layer for 7 days after which they were fixed with 3.7% formaldehyde, permeabilized and blocked with 2% BSA and 0.2% Triton-X, and incubated overnight at 4°C with primary antibodies against CD31 and Ki67. DAPI (3 µmol/L) was used to visualize cell nuclei. Alexa 488 and Alexa 567 secondary antibodies were used for detection. Image stacks (5 µm interval) were acquired with a LSM510 META Zeiss confocal microscope using a Zeiss Fluar 10x/0.5 objective at 405/488/543 nm excitation. Image stacks were processed and analyzed using Fiji/ImageJ (Schindelin et al., 2012) . Prior to analysis, noise was removed from the image stacks using the despeckle function. Image stacks were then subjected to Gaussian smoothing and endothelial invasion (CD31 staining) was quantified by manual counting of CD31 positivity >5 µm from the plane of focus. Depth of invasion was quantified using View5D.
Aortic rings angiogenesis assay
Mouse aortic ring angiogenesis assay was performed as described previously . Briefly, thoracic aortas were excised from WT and CypD KO mice, cleaned from extraneous fat and dissected into 0.5-1 mm thickness rings. Aortic rings were serum-starved overnight in Opti-MEM reduced serum medium (Invitrogen) and embedded in collagen type I matrix in 96 well plates, 1 ring/well. Rings were fed with 30 or 90 ng/ml VEGF every 3 rd day for 9 days, fixed in formalin, stained with DAPI and imaged with a Zeiss Axiovert200 fluorescence microscope equipped with an Olympus Color3 camera using a Zeiss Fluar 5x/0.25 objective. The number of primary and secondary sprouts was quantified in a blinded manner for each ring.
Wound healing assay
To induce tissue wounding, mouse ear pinna was excised using a 0.5 mm biopsy punch. 3 WT mice and 3 Ppif KO mice were used per group, and the punch was performed on both ears. Pictures of the wound were taken biweekly in order to quantify the wound area. Microvascular changes during wound healing were visualized and quantified weekly by optical microangiography (OMAG) (Jung et al., 2013) , a recently developed non-invasive optical coherence tomography technique capable of producing 3-D images of dynamic blood perfusion within microcirculatory tissue beds with capillary resolution . Before and during the OMAG imaging mice were anesthetized with isoflurane (0.2 L/min oxygen and 0.8 L/min air) by applying a face mask. Hair on the ear pinna was removed by application of Nair (Church and Dwight Co., Inc, Princeton, New Jersey) and the pinna was immobilized with double-sided tape onto a glass slide to minimize motion artifacts. For each animal, a series of three-dimensional OMAG data volumes were acquired around the punch hole immediately after the punch (baseline), and at 7 and 14 days after the punch. The OMAG data were post-processed to provide microvasculature maps using OMAG algorithms as described . To obtain vessel area density, OMAG images were processed in Fiji/ImageJ (Schindelin et al., 2012) using a low pass filter followed by adaptive thresholding to generate binary images (Reif et al., 2012) . Vessel area density was calculated by dividing the number of white pixels representing the vessels in the binary image to the total number of pixels in the image. To estimate neovascularization during wound healing, the area depleted of vessels at day 1 after the tissue excision was delineated and vessel area density was measured within the same region at day 14 after wounding.
Statistical analysis
The data are shown as mean ± SEM of 3 or more independent experiments. Statistical significance was assessed using Student's t test or two-way ANOVA test with Tukey post-hoc analysis, and p values <0.05 were considered statistically significant.
Reagents
Pan-Acetylated lysine, PTEN, GAPDH, Akt and pAkt antibodies were from Cell Signaling. SIRT1 and MnSOD antibodies were from Invitrogen, VEGFR was from Fisher Thermo Scientific. CD31, Ki-67, Cyclophilin D, complex I, II, III and IV antibodies were from Abcam. NMN and nicotinamide were from Sigma-Aldrich and trichostatin A from Cayman Chemical. 
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